WallStreetZenWallStreetZen

NASDAQ: STEX
Streamex Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for STEX

Based on 1 analyst offering 12 month price targets for Streamex Corp

Min Forecast
$10.00+110.97%
Avg Forecast
$10.00+110.97%
Max Forecast
$10.00+110.97%

Should I buy or sell STEX stock?

Based on 1 analyst offering ratings for Streamex Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although STEX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates STEX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their STEX stock forecasts and price targets.

STEX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-06-06

1 of 1

Forecast return on equity

Is STEX forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is STEX forecast to generate an efficient return on assets?

Company
-4.97%
Industry
9.91%
STEX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

STEX earnings per share forecast

What is STEX's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.26
Avg 2 year Forecast
-$0.17

STEX revenue forecast

What is STEX's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$0.0-100%
Avg 2 year Forecast
$0.0-100%
STEX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STEX revenue growth forecast

How is STEX forecast to perform vs Medical Devices companies and vs the US market?

Company
-100%
Industry
6.04%
Market
1,351.27%
STEX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STEX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STEX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
STEX$4.74$10.00+110.97%Buy
LNSR$11.90N/AN/A
ANIK$9.68$15.00+54.96%Buy
MXCT$1.51$6.00+297.35%Strong Buy
LUCD$1.25$3.88+210.00%Strong Buy
View Top Medical Device Stocks

Streamex Stock Forecast FAQ

Is Streamex Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: STEX) stock is to Buy STEX stock.

Out of 1 analyst, 0 (0%) are recommending STEX as a Strong Buy, 1 (100%) are recommending STEX as a Buy, 0 (0%) are recommending STEX as a Hold, 0 (0%) are recommending STEX as a Sell, and 0 (0%) are recommending STEX as a Strong Sell.

If you're new to stock investing, here's how to buy Streamex stock.

What is STEX's earnings growth forecast for 2025-2026?

(NASDAQ: STEX) Streamex's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 28.7%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,754.17%.

Streamex's earnings in 2025 is -$26,246,000.On average, 3 Wall Street analysts forecast STEX's earnings for 2025 to be -$8,011,793, with the lowest STEX earnings forecast at -$7,697,605, and the highest STEX earnings forecast at -$8,247,434.

In 2026, STEX is forecast to generate -$5,448,019 in earnings, with the lowest earnings forecast at -$5,234,371 and the highest earnings forecast at -$5,608,255.

What is STEX's revenue growth forecast for 2025-2026?

(NASDAQ: STEX) Streamex's forecast annual revenue growth rate of -100% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,351.27%.

Streamex's revenue in 2025 is $13,000.On average, 3 Wall Street analysts forecast STEX's revenue for 2025 to be $0, with the lowest STEX revenue forecast at $0, and the highest STEX revenue forecast at $0.

In 2026, STEX is forecast to generate $0 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $0.

What is STEX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: STEX) forecast ROA is -4.97%, which is lower than the forecast US Medical Devices industry average of 9.91%.

What is STEX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year STEX price target, the average STEX price target is $10.00, with the highest STEX stock price forecast at $10.00 and the lowest STEX stock price forecast at $10.00.

The Wall Street analyst predicted that Streamex's share price could reach $10.00 by Jun 6, 2026. The average Streamex stock price prediction forecasts a potential upside of 110.97% from the current STEX share price of $4.74.

What is STEX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: STEX) Streamex's current Earnings Per Share (EPS) is -$1.03. On average, analysts forecast that STEX's EPS will be -$0.26 for 2025, with the lowest EPS forecast at -$0.25, and the highest EPS forecast at -$0.26. In 2026, STEX's EPS is forecast to hit -$0.17 (min: -$0.17, max: -$0.18).

What is STEX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: STEX) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.